HOME › DRUGS › CASIRIVIMAB;IMDEVIMAB
ACTIVE SUBSTANCE / INN

CASIRIVIMAB;IMDEVIMAB

Brand name(s): Ronapreve
EMA LISTED
WITHDRAWN
COVID-19 virus infection
ACTIVE SUBSTANCE
Casirivimab;Imdevimab
REGULATORS
EMA
SPONSORS / MAH
Roche Registration GmbH 
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RonapreveRoche Registration GmbH Withdrawn12/11/2021COVID-19 virus infection

FULL INTELLIGENCE ON CASIRIVIMAB;IMDEVIMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →